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Abstract
Background: Cellular responses to aging and oxidative stress are regulated by type 1 insulin-like
growth factor receptor (IGF-1R). Oxidant injury, which is implicated in the pathophysiology of a
number of respiratory diseases, acutely upregulates IGF-1R expression in the lung. This led us to
suspect that reduction of IGF-1R levels in lung tissue could prevent deleterious effects of oxygen
exposure.
Methods: Since IGF-1R null mutant mice die at birth from respiratory failure, we generated
compound heterozygous mice harboring a hypomorphic (Igf-1rneo) and a knockout (Igf-1r-) receptor
allele. These IGF-1Rneo/- mice, strongly deficient in IGF-1R, were subjected to hyperoxia and
analyzed for survival time, ventilatory control, pulmonary histopathology, morphometry, lung
edema and vascular permeability.
Results: Strikingly, after 72 h of exposure to 90% O2, IGF-1Rneo/- mice had a significantly better
survival rate during recovery than IGF-1R+/+ mice (77% versus 53%, P < 0.05). The pulmonary injury
was consistently, and significantly, milder in IGF-1Rneo/- mice which developed conspicuously less
edema and vascular extravasation than controls. Also, hyperoxia-induced abnormal pattern of
breathing which precipitated respiratory failure was elicited less frequently in the IGF-1Rneo/- mice.
Conclusion:  Together, these data demonstrate that a decrease in IGF-1R signaling in mice
protects against oxidant-induced lung injury.
Background
Critical-care patients, such as premature newborns or
adults suffering from severe respiratory illness, often need
high concentrations of oxygen to maintain adequate
blood oxygenation. Yet, high oxygen concentrations for
extended periods of time are toxic and can lead to
impaired lung function, respiratory failure and even death
[1-3]. The sequence of events resulting in acute lung injury
has been described in different models and involves alve-
olar edema, surfactant dysfunction, interstitial fibrosis [4-
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6], and subsequent deterioration of lung function [7]. At
the cellular level, hyperoxia generates oxygen-derived free
radicals that lead to damaged lung parenchymal, epithe-
lial and endothelial cells [3].
Insulin-like growth factor-I (IGF-I) and its cognate recep-
tor, the type 1 insulin-like growth factor receptor (IGF-
1R), are known to be key modulators of growth and injury
repair processes in several organs, including the lung. IGF-
1R is essential for normal growth, development and dif-
ferentiation, and mediates signals for the suppression of
apoptosis and promotion of mitogenesis [8]. Interest-
ingly, we [9] and others [10] have observed that IGF-1R
expression was more intense in areas of increased prolifer-
ation in the developing lung of rodents. Furthermore,
exposure of adult rats to prolonged hyperoxia was associ-
ated with an increase in IGF-1R immunostaining in the
lung, in the vicinity of cells expressing IGF-I [11]. Like-
wise, the expression pattern of IGF-I and IGF-1R in the
lung is altered in various diseases that require oxygen ther-
apy, including cystic fibrosis [12,13], lung fibrosis [14-
16], acute respiratory distress syndrome or bronchopul-
monary dysplasia [14]. Together, these observations have
led to the suggestion that IGF signaling may be important
in the pathogenesis of oxygen-induced lung injury.
Interestingly, a link between IGF signaling and resistance
to oxidative stress was found in studies on the biological
mechanisms of aging. Holzenberger et al. recently showed
that mutant mice with only one functional copy of the Igf-
1r  gene had an extended lifespan [17]. Remarkably,
increased longevity in these mutants was associated with
enhanced resistance to paraquat-induced oxidative stress,
while there was a slight reduction in body growth and no
alteration in metabolism, food intake, body temperature
or onset of sexual maturation and fertility. These findings
suggest that the final common pathway of IGF-1R action
in the aging process may be modulation of the cellular
response to oxidative damage.
In this study, we sought to determine whether decreased
functional levels of IGF-1R could prevent deleterious
effects of oxygen exposure in the lung. Since IGF-1R null
mutant mice die at birth from respiratory failure, we gen-
erated compound heterozygous mice harboring a hypo-
morphic (Igf-1rneo) allele and a knockout (Igf-1r-) allele
[18]. These IGF-1Rneo/- mice, strongly deficient in IGF-1R,
were subjected to hyperoxia and analyzed for survival
time, ventilatory function, pulmonary histopathology,
morphometry, lung edema and vascular permeability.
Methods
Animals
The mice were studied according to European recommen-
dations on animal ethics. They were kept under standard
conditions (average ambient temperature 23°C, 12/12-h
light/dark cycle) with water and food provided ad libitum
throughout the study. Experiments were performed on
male and female mice with a 129/Sv genetic background.
They were either deficient in IGF-1R (IGF-1Rneo/-) or had
normal levels of IGF-1R (IGF-1R+/+). The hypomorphic
IGF-1Rneo allele was created by introducing a neomycin
resistance cassette (neo) in intron 2 of the receptor gene
using homologous recombination, and the receptor null
allele (IGF-1R-) resulted from the complete elimination of
exon 3, which encodes the type 1 IGF receptor ligand-
binding domain [18]. We compared heterozygous IGF-
1Rneo/- mice (n = 78) with their wild-type IGF-1R+/+ litter-
mates (n = 84), which served as controls. Body weight and
body temperature were systematically measured prior to
each experiment. Seven-week-old mice were analyzed at
three different time periods: under basal conditions, after
hyperoxic exposure and/or during post-hyperoxia recov-
ery. Genotyping of the mice was performed by PCR.
Amplification conditions were as follows: 95°C for 3 min,
and 35 cycles at 95°C for 35 s, 55°C for 45 s and 72°C for
1 min, with a final elongation step at 72°C for 7 min. To
detect IGF-1Rneo (hypomorphic), IGF-1R- (knockout) and
IGF-1R+ (wild-type) alleles simultaneously, three oligonu-
cleotides were used. The primer sequences were 5'-CAT-
GGGTGTTAAATGTTAATGGC-3' (Nex, sense-oriented), 5-
ATGAATGCTGGTGAGGGTTGTCTT-3' (Nvl, sense-ori-
ented) and 5'-ATCTTGGAGTGGTGGGTCTGTTTC-3'
(Nmt2, antisense-oriented).
Hyperoxic exposure and post-hyperoxia recovery
To induce hyperoxic lung injury, mice were exposed to
90% O2 for 72 h in a sealed Plexiglas chamber of 9.7 liters,
at 22–24°C. The O2 and CO2 levels in the chamber were
monitored by O2 and CO2 analyzers (OM-11 and LB-2,
respectively; Beckman Instruments, Schiller Park, IL,
USA). Oxygen flow rate was adjusted to 1.5 L/min. The
CO2 level was always kept below 0.5%. Following hyper-
oxia, the mice were then placed in normoxic basal condi-
tions. The survival study was performed in 31 IGF-1Rneo/-
and 30 IGF-1R+/+ mice. They were checked every 2 h.
Ventilatory physiology
Analyses were performed sequentially in the same 5 IGF-
1Rneo/- and 6 IGF-1R+/+ mice. There were three experimen-
tal conditions: before hyperoxia (in the basal, normoxic
conditions), after hyperoxia, and during the post-hyper-
oxia recovery. Ventilatory parameters were recorded in
awake and unrestrained mice placed in a whole-body
plethysmograph, by using the barometric method [19].
The pressure signal resulting from breathing was detected
using a differential pressure transducer (Validine DP103/
12; Validine, Northridge, CA, USA) connected to the ani-
mal chamber (400 mL) and to a reference chamber of the
same volume. The spirogram was recorded and stored onRespiratory Research 2005, 6:31 http://respiratory-research.com/content/6/1/31
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a computer using respiratory acquisition software (CIO-
DAS 1602/16 interface and ELPHY software) for analysis
off-line. Calibration was performed at the beginning of
experiments by several injections of 50 µL air into the
chamber. Each animal was weighed and placed in the
chamber. A thermistal probe (BIO-BIT14) was inserted
rectally and secured in place at the base of the tail and on
the wall of the chamber. A protective muff was placed
around the mouse to prevent stress. The protocol con-
sisted of recording ventilatory parameters and rectal tem-
perature before and immediately after the 72 h of
hyperoxia. Measurements were made every 5 min while
the mouse was breathing the following gas mixtures: 20
min in hyperoxia (100% O2) to obtain baseline values, 20
min in normoxia (21% O2), 10 min in mild hypoxia
(12% O2) and 10 min in severe hypoxia (10% O2). The
mouse was then allowed to recover in normoxia for 24 h
prior to changing the experimental conditions, and the
same protocol of recording was again applied. The CO2
concentration in the chamber was always < 1% at the end
of each session. The following variables were measured
and calculated by a computer-assisted method: minute
ventilation (VE) and its two components: tidal volume
(VT) and respiratory frequency (fR). For each 5 min record-
ing, values were averaged on 50–100 contiguous breaths.
Measurement of relative lung weight and lung histology 
analysis
Mice were weighed and anesthetized with sodium pento-
barbital (60 mg/kg). After bleeding, the lung was either
immediately removed to measure the relative lung weight,
or perfused in situ with neutral-buffered 10% formalin (15
cm H2O pressure) for histological analysis. The ratio of
lung weight to body weight was determined in 11 IGF-
1Rneo/-and 16 IGF-1R+/+ mice under basal conditions.
For histological analysis, the trachea was ligated, the lungs
were removed and fixed overnight in 10% formalin, and
embedded in paraffin. Lung histology was documented
both under basal conditions and after hyperoxic exposure,
using 4 IGF-1Rneo/- and 4 IGF-1R+/+ mice for each condi-
tion. Three random 4-µm paraffin-embedded tissue sec-
tions from four different lungs from each group were
stained with hematoxylin-eosin. The histopathology was
reviewed in a blinded manner with respect to which group
or mouse was being reviewed, using characteristic patho-
logical traits including: alveolar destruction, edema, hem-
orrhage and hyaline membrane deposition.
Morphometric analysis was performed under basal condi-
tions and after hyperoxic exposure, using 4 IGF-1Rneo/-
and 4 IGF-1R+/+ mice for each condition. Images were cap-
tured using the software TRIBVN ICS (release 2.04;
IMAGIC, Bildverarbeitung AG, Glattbrug, Zürich, Switzer-
land). Six randomly selected fields (magnification 20×)
were assessed in each mouse for (i) intra-alveolar hemor-
rhage and (ii) fibrin deposition which are easily identifia-
ble pathological processes. Each process was scored on a
scale of 0 to 4. Scores were assessed twice in a blinded
manner. Zero with no apparent injury; 1, mild injury with
<25% lung involvement; 2, moderate injury with 25–50%
lung involvement; 3, severe injury with 50–75% lung
involvement; 4, very severe injury with >75% lung
involvement. An overall score of hyperoxia-induced lung
injury was obtained by summation of scores of hemor-
rhage and of fibrin deposition. A mean ± SEM was gener-
ated from each group. In addition, five fields from each
mouse were selected for the presence of perivascular
edema, and used to quantify the edema by the ratio
between the surface of edema and the surface of the vessel.
Surface was estimated using a one-dimensional grid of
points spaced 50 µm apart which was overlaid on each
field.
Lung edema analysis and vascular permeability by Evans 
Blue assay
Pulmonary edema was determined from the ratio
between fresh lung weight at autopsy and dry weight.
Lungs were dried at 80°C until their weight remained con-
stant over 24 h. The wet-to-dry lung weight was assessed
under basal conditions using 4 IGF-1Rneo/- and 4 IGF-1R+/
+ mice, and after hyperoxic exposure using 8 IGF-1Rneo/-
and 7 IGF-1R+/+ mice for each experiment.
Vascular permeability related to lung injury was measured
using the Evans Blue dye extravasation assay, as previously
described [20]. The animals were anesthetized with a
combination of ketamine (24 mg/kg) and xylazine (36
mg/kg), and received 30 mg/kg Evans Blue dye dissolved
in 0.9% saline at a final concentration of 20 mg/ml by jug-
ular vein injection, 10 min before sacrifice. The lungs were
then perfused with 5 ml PBS containing 5 mM EDTA until
all the blood has been removed. They were then dissected
out, weighed and incubated at room temperature for 24 h
in 4 ml formamide per g tissue (Sigma, St. Louis, MO,
USA). The extravasation of Evans Blue-labeled albumin
from the tracheobronchial microcirculation was quanti-
fied by measuring the optical density (OD) of the forma-
mide extracts at wavelength of 620 nm. The quantity of
Evans Blue dye extravasated in the airway tissues,
expressed in ng/mg of dry tissue weight, was interpolated
from a standard curve of Evans Blue concentrations (0.5–
10 µg/ml). The Evans Blue dye assay was assessed both
under basal conditions using 5 IGF-1Rneo/- and 6 IGF-1R+/
+ mice, and after hyperoxic exposure using 6 IGF-1Rneo/-
and 7 IGF-1R+/+ mice for each experiment.
Statistical analysis
The values for all animals within each experimental group
were averaged and standard deviations (SD) calculated.Respiratory Research 2005, 6:31 http://respiratory-research.com/content/6/1/31
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Statistical comparison of the results was performed
between IGF-1R+/+ and IGF-1Rneo/- mice, and between nor-
moxia and hyperoxia-treated groups, using the unpaired
ANOVA t-test and the multiple comparison test (Bonfer-
roni). The significance between the survival rate of two
groups was determined by Kaplan-Meier analysis using
the Cox statistical test. Differences were considered signif-
icant if P < 0.05.
Results
Survival of compound IGF-1Rneo/- mice
To assess the importance of IGF-1R for postnatal lung
function, compound mice that harbored a hypomorphic
(Igf-1rneo) allele and a knockout (Igf-1r-) allele were gener-
ated. As previously described [21], IGF-1Rneo/- mice consti-
tutively express only 25% of the IGF-1R levels typically
found in wild-type (IGF-1R+/+) mice. In the IGF-1Rneo/-
mice, survival up to 6 months and fertility in young adults
were unaltered (data not shown). Body weight of IGF-
1Rneo/- and IGF-1R+/+ female mice did not differ signifi-
cantly (-3.8%, NS), while the body weight of IGF-1Rneo/-
males was slightly reduced compared to IGF-1R+/+ litter-
mates (-16.6%, P < 0.05). In both female and male mice,
the lung to body weight ratio was similar in both geno-
types (Fig. 1A). Under basal normoxic conditions, histo-
logical examination of the lungs of IGF-1Rneo/- and IGF-
1R+/+ mice did not reveal fibrosis, nor inflammation, nor
remodeling of intrapulmonary airways and lung paren-
chyma (Fig. 1B).
To investigate whether IGF-1R contributed to hyperoxia-
induced lung injury, IGF-1Rneo/- mice and their wild-type
littermate controls were exposed to 90% O2 for 72 h and
their survival was assessed during a recovery period of 48
h under normoxic conditions (Fig. 2). Forty-eight hours
actually corresponded to the critical period during which
mice either developed lethal respiratory symptoms or sur-
vived. The percentage of survivors following the initial
period of hyperoxia was significantly greater in the IGF-
1Rneo/- mice (77%) than in IGF-1R+/+ mice (53%) (P <
0.05). Moreover, mortality predominantly affected mice
within the initial 24-h period after hyperoxia (Fig. 2).
Ventilatory parameters in IGF-1Rneo/- mice
We recorded ventilation in conscious IGF-1Rneo/- and IGF-
1R+/+ mice placed in a whole-body plethysmograph while
breathing 90% O2, 21% O2 or under hypoxia (at 12% and
10% O2). Baseline ventilation and control of breathing
during hypoxia were assessed by measuring the respira-
tory parameters such as minute ventilation (VE) and its
two components: respiratory frequency (fR) and tidal vol-
ume (VT) before hyperoxia, after hyperoxia and during
recovery in room air.
Before hyperoxia (control conditions), baseline minute
ventilation (VE) was slightly greater in IGF-1Rneo/- mice
than in IGF-1R+/+ mice because of a greater tidal volume
(VT), while respiratory frequency (fR) was similar in the
two groups (Table 1). During hypoxia, VE significantly
increased under 12% and 10% O2 in both groups, this
effect being essentially due to a large increase in fR (Fig. 4).
During this protocol, mean values of VE were constantly
greater in IGF-1Rneo/- mice than in IGF-1R+/+ mice. How-
ever, the magnitude of the response to hypoxia – which
was obtained by calculating the per cent change in VE dur-
ing severe hypoxia (10% O2) relative to hyperoxia – was
similar in the two groups.
Following hyperoxia, the mice of both genotypes mani-
fested an abnormal pattern of breathing. This pattern was
Lung weight and histology under basal conditions Figure 1
Lung weight and histology under basal conditions. (A) 
Mean values (×100) of lung-to-body weight ratio (± SD) in 
IGF-1R+/+ mice (male: n = 11; female: n = 5) and IGF-1Rneo/- 
mice (male: n = 7; female: n = 4). (B) Representative histol-
ogy of hematoxylin-eosin stained lung sections from IGF-1R+/
+ and IGF-1Rneo/- mice. Magnification: 10× objective.
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Survival rate following exposure to 90% oxygen Figure 2
Survival rate following exposure to 90% oxygen. The survival times of IGF-1R+/+ mice (male: n = 15; female: n = 15) and 
IGF-1Rneo/- mice (male: n = 16; female: n = 15) were measured following exposure to 90% oxygen. Data are expressed as per-
centage of mice alive at each time point. The asterisk indicates significant differences between IGF-1R+/+ and IGF-1Rneo/- mice, 
as determined by Kaplan-Meier analysis; P < 0.05.
Ventilatory responses before and after hyperoxia, and during recovery Figure 4
Ventilatory responses before and after hyperoxia, and during recovery. Minute ventilation (VE) in response to 
decreasing levels of inspired O2. In each one of the three conditions, mean values (± SD) of VE in IGF-1R+/+ and IGF-1Rneo/- 
mice were recorded under 90% O2, 21% O2 and at two levels of hypoxia (12% and 10% O2). Values with asterisks are signifi-
cantly different from control values at 90% O2. Crosses indicate significant differences from normoxic control values, and 
asterisks indicate significant differences between IGF-1R+/+ and IGF-1Rneo/- mice; P < 0.05.
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characterized by a deep and slow breathing with expira-
tory pauses, particularly in the IGF-1R+/+ mice (Fig. 3).
Mean values of baseline VE were substantially increased
compared with control conditions in both groups, this
effect being due to a large increase in VT, whereas fR was
moderately decreased (Table 1). However, the hyperoxia-
induced increase in VE was greater in IGF-1Rneo/- mice
because of a less pronounced diminution of fR. During
hypoxia, VE did not increase under 12% or 10% O2 in
either of the genotypes, which indicates that prolonged
hyperoxic exposure abolished the ventilatory response to
hypoxia (Fig. 4).
During recovery in room air, VE and VT remained elevated
while fR recovered its control values in both IGF-1Rneo/-
and IGF-1R+/+ mice (Table 1), and the stimulation of
ventilation by hypoxia was restored (Fig. 4). Again, mean
values of VE at 12% and 10% O2 were significantly greater
in IGF-1Rneo/- mice than in IGF-1R+/+ mice, but the magni-
tude of the response was similar in both groups.
IGF-1R deficiency confers protection in 90% O2
As shown in Fig. 5, exposure to 90% O2 for 72 h caused
histological changes in the lungs of both IGF-1R+/+ and
IGF-1Rneo/- mice, but injury was more severe in the lungs
taken from IGF-1R+/+  mice. The histological lesions
included alveolar destruction, hyaline membrane forma-
tion, hemorrhage, and perivascular and peribronchiolar
edema (Fig. 5). In contrast, hyperoxia-induced lung
lesions were remarkably milder in IGF-1Rneo/- mice, with
less edema and hemorrhage.
Lung morphometry was used to measure the degree of
hyperoxic injury. Analysis of a cumulative score which
reflects both intra-alveolar hemorrhage and fibrin deposi-
tion revealed a significantly reduced score in hyperoxic-
exposed IGF-1Rneo/- mice as compared to IGF-1R+/+ (Fig.
6A). Likewise, quantitative assessment of perivascular
edema, as shown in Fig. 6B, confirmed that IGF-1Rneo/-
were protected from hyperoxia induced lung injury, and
indistinguishable from IGF-1R+/+  mice under basal
conditions.
We quantified lung damage in IGF-1Rneo/- and IGF-1R+/+
mice using two parameters which are either relevant to
edema or to vascular permeability (Fig. 6). Wet-to-dry
lung weight ratio, which was measured as a supplemen-
tary mean to quantify edema, was noticeably reduced in
IGF-1Rneo/- mice (-26%, P < 0.05) (Fig. 6C). This data was
consistent with histomorphometric results (Fig. 6B).
Moreover, lung vascular permeability, which was quanti-
fied by measuring the extravasation of Evans Blue dye, was
reduced in IGF-1Rneo/- mice (-49%, P < 0.05) (Fig. 6D).
Discussion
The main aim of the present study was to evaluate the
importance of IGF-1R in acute hyperoxic lung injury by
studying survival time, respiratory physiology and
pulmonary histology. Since complete inactivation of Igf-
1r is lethal at birth due to respiratory failure [18,22], we
combined a knockout allele (Igf-1r-) and a hypomorphic
allele (Igf-1rneo) in order to generate viable mice with
Table 1: Ventilatory parameters at baseline (90% O2) before hyperoxia, after hyperoxia and during recovery.
IGF-1R+/+ IGF-1Rneo/-
Before hyperoxia After hyperoxia During recovery Before hyperoxia After hyperoxia During recovery
VE 2.03 ± 0.17 2.35 ± 0.32 # 2.84 ± 0.69# 2.27 ± 0.22 * 2.93 ± 0.37 *# 3.30 ± 0.62#
VT 10.0 ± 0.5 15.8 ± 2.0# 14.4 ± 2.2# 11.2 ± 0.8 * 15.2 ± 1.1# 14.8 ± 1.1#
fR 203 ± 9 142 ± 30# 196 ± 32 203 ± 21 192 ± 18 *# 222 ± 35
Values are mean parameters ± SD in IGF-1R+/+ mice (n = 6) and IGF-1Rneo/- mice (n = 5) mice; VE, minute ventilation expressed in ml/min/g, VT, tidal 
volume in µl/g, fR, respiratory frequency in c/min; # significant difference relative to control before hyperoxia; * significant difference between the 
two genotypes (P < 0.05).
Respiratory pattern before and after hyperoxia Figure 3
Respiratory pattern before and after hyperoxia. Typi-
cal respiratory pattern in a control IGF-1R+/+ mouse (upper 
traces) and in an IGF-1Rneo/- mouse (lower traces) under 
basal conditions and following hyperoxia. Expiratory pauses 
were observed in most control mice but not in IGF-1Rneo/- 
mice.
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markedly reduced levels of IGF-1R [21]. Although hap-
loinsufficiency of the Igf-1R gene in humans has been sus-
pected to be associated with lung hypoplasia [23], the low
levels of IGF-1R expressed in IGF-1Rneo/- mice were suffi-
cient to ensure normal lung growth (Fig. 1). Thus, these
mice provided a new way of exploring the in vivo effects of
a major deficiency in IGF-1R in the adult lung. The most
striking result of this study was the improved survival of
the IGF-1Rneo/- mutant mice following hyperoxic injury,
associated with increased protection against pulmonary
damage. These results support the idea that IGF-1R plays
a critical role in the regulation of pulmonary resistance to
oxidative stress.
Recently, using paraquat-induced stress which is known
to cause multi-organ failure, Holzenberger et al. have
shown that deficiency in IGF-1R is associated with
improved oxidative stress resistance, as assessed by pro-
longed survival [17]. In this study, we further evaluated
IGF-1R as one component of the mechanistic determi-
nants of the lung injury process, and focused our attention
on survival after hyperoxic-lung injury. IGF-1Rneo/- mutant
mice and their wild-type littermate controls were exposed
to hyperoxia-induced oxidative stress, which has been
used extensively in rodents as a valuable model of acute
respiratory distress. Because sensitivity to hyperoxia has
been described to be strain-dependent [24], these experi-
ments were performed using IGF-1R- and IGF-1Rneo alleles
Histology following hyperoxic injury Figure 5
Histology following hyperoxic injury. Hematoxylin-eosin stained lung sections of (a) IGF-1R+/+, and (b) IGF-1Rneo/- mice 
following 72 h of hyperoxic exposure, illustrating perivascular and peribronchiolar edema as indicated by asterisks. Magnifica-
tion: 10× objective. Representative histology of lung sections demonstrates (c) focal alveolar hemorrhages (black arrow) and 
hyaline membrane formation (gray arrow) in IGF-1R+/+ lungs, and (d) minimal lesions in IGF-1Rneo/- mice. Magnification: 40× 
objective.
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Hyperoxia-induced lung injury, lung edema and vascular permeability Figure 6
Hyperoxia-induced lung injury, lung edema and vascular permeability. Parameters of lung damage were considered 
under basal conditions and following hyperoxia. (A) Lung injury scores from IGF-1R+/+ (n = 4) and IGF-1Rneo/- (n = 4) mice 
under basal conditions (normoxia) and under hyperoxia. A cumulative score was based on evaluation of hemorrhage and 
intraalveolar deposition (6 random sections per lung). (B) Quantitated perivascular edema from IGF-1R+/+ (n = 4) and IGF-
1Rneo/- (n = 4) mice under basal conditions (normoxia) and under hyperoxia. Surface of perivascular edema was reported to the 
surface of the vessel, and noted SE/SV (5 selected sections per lung). (C) Lung edema was determined as mean values (± SD) of 
wet-to-dry lung weight ratio under basal conditions (normoxia) in IGF-1R+/+ (n = 4) and IGF-1Rneo/- (n = 4) mice, and under 
hyperoxia in IGF-1R+/+ (n = 7) and IGF-1Rneo/- (n = 8) mice. (D) Evans Blue dye extravasation was assessed as mean values (± 
SD) in IGF-1R+/+ (n = 13) and IGF-1Rneo/- (n = 11) mice. Crosses indicate significant differences between hyperoxic and nor-
moxic values in IGF-1R+/+ mice, and asterisks indicate significant differences between IGF-1R+/+ and IGF-1Rneo/- mice under 
hyperoxic conditions; P < 0.05.
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in a pure 129/Sv genetic background. Consistent with pre-
vious findings [25], acute respiratory distress was
observed in our mice when they were exposed to > 90%
oxygen for 72 h. Overall, IGF-1Rneo/- mice were more
resistant to hyperoxic stress than littermate controls (Fig.
2,3,4,5,6). These results, together with the induction of
IGF-1R in response to high oxygen concentration [11,14],
directly implicate IGF-1R in the development of oxidant-
mediated lung injury, and indicate that deficiency in IGF-
1R is associated with a higher capacity to endure and to
recover from oxidant-induced injury. There are numerous
mechanisms that can potentially interfere with resistance
to hyperoxia, involving antioxidant enzymes, inflamma-
tory mediators, cell cycle progression regulators, apopto-
sis and anti-apoptosis factors, endothelial cell-specific
factors and the extracellular matrix repair system.
Although assessment of the importance of IGF-1R in each
of these mechanisms warrants specific attention, we made
it our priority to determine which of the physiological
traits in these mice is most likely to account for the phe-
notypic differences in response to acute lung injury.
Hyperoxic exposure is known to induce severe lung dys-
function, which can dramatically affect gas exchange.
Indeed, several studies have shown that prolonged hyper-
oxia causes a reduction in lung compliance [26,27], and
markedly alters the control of breathing through attenuat-
ing both carotid chemosensory responses and chemore-
flex responses to hypoxia [28]. We hypothesized that such
alterations may influence the resistance to oxidative stress,
and subsequent survival of the mice. We found that hyper-
oxic exposure of the mice of either genotype, IGF-1Rneo/-
and IGF-1R+/+, abolished the ventilatory response to
hypoxia, mainly caused by the absence of responsiveness
of respiratory frequency (Fig. 4). These results clearly sug-
gest that prolonged hyperoxia markedly alter carotid
chemosensory activity and are consistent with previous
studies in unanesthetized cats [1] and rats [29]. Interest-
ingly, we observed also that the deleterious effects of
hyperoxia on the hypoxic ventilatory drive were fully
reversible under recovery conditions in room air. Thus,
the blunted ventilatory response to hypoxia immediately
after hyperoxic injury probably plays a critical role in the
development and progression of respiratory distress
exhibited by the mice.
It is noteworthy that striking differences in pattern of
breathing and ventilation were observed between IGF-
1Rneo/- and IGF-1R+/+ mice, which may well contribute to
the improved survival of the former group after hyperoxia.
In particular, the abnormal pattern of breathing induced
by hyperoxia, which limited the ventilatory response to
hypoxia and precipitated respiratory failure, was more
often elicited in the control mice than in the IGF-1Rneo/-
mice (Fig. 3). Also, minute ventilation at baseline, as well
as in response to hypoxia, was greater in the IGF-1Rneo/-
mice. This latter finding suggests a pulmonary role for
IGF-1R in response to hypoxia. This is consistent with a
previous observation in which IGF-1R mRNA levels were
specifically increased by 200% in the lung in response to
hypoxia [30].
Pathogenesis of lung injury after hyperoxia has been stud-
ied extensively in mice. Prominent features include exten-
sive alveolar and endothelial cell death, leading to
disruption of the alveolo-capillary barrier, high pulmo-
nary microvascular permeability and pulmonary edema.
The hyperoxic morphological phenotype that we
quantified by morphometry at 72 h of hyperoxia was con-
sistently characterized by pulmonary edema, intra-alveo-
lar hemorrhage and hyaline membrane formation in IGF-
1R+/+, but was remarkably milder in the IGF-1Rneo/- mice
(Figs. 5 and 6). These results are directly supportive of
decreased sensitivity to hyperoxia being associated with
IGF-1R deficiency. Protective mechanisms in which IGF-
1R is suspected to interfere may include changes in the
defense against accumulation of oxygen free radicals,
although a recent study in patients with respiratory dis-
tress syndrome or bronchopulmonary dysplasia indicated
only moderate induction of the antioxidant defense sys-
tem [31]. Likewise, the response of mice to prolonged
hyperoxia was not associated with altered expression of
classical antioxidant enzymes such as catalase, MnSOD
and Cu-Zn SOD [32]. Other differences may reside in the
inflammatory response that leads to an influx of protein-
rich fluid to the airspaces.
By measuring changes in the ratio of wet-to-dry lung
weight and in the Evans Blue extravasation, we found
decreased permeability of the alveolo-capillary mem-
brane in the lungs of IGF-1Rneo/- mice compared with IGF-
1R+/+ mice (Fig. 6). These results further led to consider
that IGF-1R may exert its influence on the integrity of alve-
olo-capillary membrane through endothelial cells.
Increased integrity of the alveolo-capillary membrane in
the mutant mice may result from enhanced survival and/
or proliferation of the alveolar and endothelial cells in
response to oxidative stress [10]. Studies have indicated
that IGF-1R is present in vascular endothelium and vascu-
lar smooth muscle of oxygen-exposed lungs, both in
patients and in animal models [11,14]. To date, most
studies on the regulation of vascular permeability have
focused on vascular endothelial growth factor (VEGF) and
related molecules. In the lung, however, their role in the
control of permeability remains controversial [33-35].
Moreover, in vivo studies on the retinal neovascularization
process have shown that VEGF is regulated through the
activation of IGF-1R. This was demonstrated using either
IGF-1R neutralizing antibody [36] or an endothelial cell-
specific knockout of IGF-1 receptor [37]. Thus, it can beRespiratory Research 2005, 6:31 http://respiratory-research.com/content/6/1/31
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speculated that the deficiency of IGF-1R in IGF-1Rneo/-
mice contributes to the protection of lung endothelium
from oxidant injury – either directly or through interme-
diary modulation of VEGF expression. Taken together,
these findings highlight the need for additional experi-
ments to elucidate the true role of IGF-1R in the regula-
tion of pulmonary permeability.
Conclusion
Understanding of the molecular mechanisms allowing
protection against pulmonary oxygen toxicity is crucial in
order to enable the development of targeted and effective
interventions aimed at preventing or alleviating oxidant-
induced acute lung injury [38]. Our results support the
novel notion that IGF signaling, for which numerous
interfering drugs are under clinical development [39],
plays an important role in the sensitivity to and recovery
from oxygen lung injury. We consider that the findings of
our study will precipitate additional research efforts to
assess whether interference with IGF-1R signaling may be
a way of reducing or preventing the development of acute
respiratory distress syndrome.
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